The American Society of Hematology has notified me that the FDA's Dr. Richard Pazdur has issued a statement concerning "Expanded Access to Investigational Drugs for Treatment Use" and "Charging for Investigational Drugs." These are two significant new rules.
Links follow (for cut and paste use).
http://edocket.access.gpo.gov/2009/pdf/E9-19004.pdf and
http://edocket.access.gpo.gov/2009/pdf/E9-19005.pdf.
Showing posts with label Investigational Drugs. Show all posts
Showing posts with label Investigational Drugs. Show all posts
Monday, August 17, 2009
Subscribe to:
Posts (Atom)
Posts
